Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 27, 2019 07:00 ET | Source: Axogen, Inc.

Axogen to Participate in the 74th Annual American Society for Surgery of the Hand Meeting

Updated outcomes data from the RANGER® Registry’s MATCHSM cohort will be presented during scientific sessions ALACHUA, Fla., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a...
August 06, 2019 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2019 Second Quarter Financial Results

ALACHUA, Fla., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
July 29, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth Conference

ALACHUA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
July 26, 2019 07:00 ET | Source: Axogen, Inc.

Axogen Announces Publication of the 100th Peer-Reviewed Clinical Paper Featuring its Product Portfolio for Peripheral Nerve Repair

ALACHUA, Fla., July 26, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
July 23, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report Second Quarter 2019 Financial Results and Host Conference Call on August 6, 2019

ALACHUA, Fla., July 23, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
May 23, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at Upcoming Investor Conferences

ALACHUA, Fla., May 23, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves,...
May 08, 2019 16:01 ET | Source: Axogen, Inc.

Axogen, Inc. Reports 2019 First Quarter Financial Results

ALACHUA, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves,...
May 02, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. Appoints New Members to Board of Directors

Quentin S. Blackford, Executive Vice President and Chief Financial Officer of Dexcom Alan M. Levine Chairman, President, and Chief Executive Officer for Ballad Health New members bring a breadth of...
April 22, 2019 07:01 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Completion of Planned Interim Analysis and One-Time Enrollment Expansion for RECON® Study

ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...
April 22, 2019 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report First Quarter 2019 Financial Results and Host Conference Call on May 8, 2019

ALACHUA, Fla., April 22, 2019 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral...